Head of Expansion at AIOS — Remote, $200-$400k/yr + .15% - 0.5% equity

ABOUT AIOS AIOS is building the world’s first full-stack AI doctor. We’re at $350M ARR, growing from $10M/yr 12 months ago. We’re the world’s fastest growing AI doctor. We’re faithfully serving >150k/mo patients via Bolt Pharmacy, our main UK brand. We’re profitable. Our strategy exists at the intersection of two strong theses: 1. The AI doctor that wins will get to escape velocity using GLP-1s, the fastest growing consumer product in history. 2. The $2T European healthcare market is overlooked by the most talented builders. Our master plan: - Step 0 → $100M/yr by end of 2025: We went from $10M to $100M in 6 months serving the UK GLP-1 market.

• Step 1 → $1B ARR by end of 2026: Over the last 12 months we've grown from 3k to 150k UK active GLP-1 patients.

• Step 2 → $10B ARR by end of 2028: Blitzscale Europe. We’ll be Europe’s largest GLP-1 provider.
• Step 3 → $100B/yr by end of 2031: Get regulatory approval across Europe for our Full Autonomous Prescribing (FAP) system. Win contracts at scale with European payers to mass replace human labor.

• Step 4 → $1T/yr by end of 2035: With one line of code and zero human time, you can use AIOS to treat any patient globally with any medication. In so doing, we’ll become the world’s first trillion-dollar healthcare company. We’re a young, founder-led company. This is still Day 1 and all our work is ahead of us.

• Work out precisely what is preventing us from launching in each priority market we’re not yet live in - Carve out the fastest compliant route into each of those markets, whether that means building the required capabilities internally, partnering with established local providers, or acquiring existing infrastructure.

• Prioritisation: You’ll determine which countries we should enter next based on market size, customer demand, unit economics, regulatory complexity and speed to launch.
• Planning: You’ll identify precisely what is blocking us from launching in each priority country, then construct the plan to plow through blockers.
• Build or Buy: You’ll choose the fastest compliant route into each market, whether that means architecting internally, partnering with established local providers, and/or acquiring existing infrastructure.
• Legal & Regulatory: You’ll make sure we have the appropriate legal entities, local/national permissions, registrations, contracts and compliance frameworks required to operate.
• Clinical: You’ll establish the clinical infrastructure required to serve patients, including helping staff the initial clinical team if building from 0.
• Supply & Fulfilment: You’ll secure reliable medication supply, pharmacy partner(s), and fulfilment infrastructure so we can launch quickly and scale without operational constraints.
• Readiness: You’ll coordinate the legal, clinical, product, operational and supply work required for our Growth team to begin testing each market as quickly as possible.
• Playbook: You’ll turn what we learn from each launch into a repeatable system, reducing the time, cost and complexity required to enter the next country.

• Locale: You’re based in the UK or Europe, and you’ve launched and/or scaled businesses across multiple European countries, namely Germany, the Netherlands, France, Spain, Italy, and/or the Nordics.
• Launches: You have personally owned taking European launches from idea to live operations.

• Judgement: You determine which markets are actually worth entering, what must be true for them to work, and whether we should build, partner, or acquire.
• Execution: You smoothly move from strategy-mode into the trenches. You’re comfortable negotiating partnerships, reviewing contracts, setting up entities, solving supply constraints, and doing whatever else is required to compliantly launch.
• Complexity: You can grok complex regulatory environments and work effectively across legal, clinical, and ops.

• Clockspeed: You learn unfamiliar markets unusually quickly. You know how to find the right people, ask sharp questions, separate real blockers from perceived blockers, and reach high-quality decisions without months of research.
• Project Management: You run several country launches concurrently without losing control of the details.

• Systems: You turn each launch into reusable scaffolding. You identify what can be standardised across Europe to continuously reduce the time required to launch.
• Ownership: You truly operate like a founder. You don’t wait for complete information, perfect resources, or somebody else to remove a blocker.

• European Expansion: You’ve launched and scaled businesses across multiple European countries, namely Germany, the Netherlands, France, Spain, Italy, and/or the Nordics.
• Evaluation: You have experience evaluating partnerships, joint ventures, licensing arrangements, or acquisitions as routes into new markets.

• AI-Native: You use AI to research markets, analyse regulations, evaluate opportunities, draft plans, automate workflows, and increase the amount you can personally execute.
• Talent: You’ve built and managed a lean, high-performance team across multiple countries.

• Founder: You’ve founded something (no matter how small), or joined a project early. You may want to start your own company in the future.
• Figure It Out: You’re one of those timeless people who could be dropped anywhere in the world, in any century, and figure out how to make progress.

• ## Compensation

• Healthcare: comprehensive medical insurance (if appropriate) - Vacation: PTO with a yearly minimum (≥2wks/yr + local national holidays) - Remote: our team is fully distributed across the world and functions fully remotely - Personal development: budget for books, courses, coaching ($1200/yr) - Personal wellness: budget for gym, health apps ($1200/yr) - Coaching: free biweekly health and work coaching so you’re sharp and healthy - Equipment: Macbook & work-from-home equipment provided as needed - What are we missing?

• Highlight specific European market entry projects you’ve led, referencing the regulatory hurdles you overcame.
• Prepare a concise case study that shows your Excel modeling skills for market sizing or financial forecasts.
• Emphasize any experience with GLP‑1 or other pharma products, as it aligns directly with AIOS’s focus.
• Showcase your ability to work async and be reliably present for midday Pacific calls; mention your preferred collaboration tools.
• During interviews, be ready to discuss how you would assess a new market’s legal and clinical readiness in a week‑long timeline.
• Negotiate equity by understanding AIOS’s current valuation ($350M ARR) and the potential upside of its expansion plan.
• Watch for red flags: unclear compensation bands and expectations of frequent weekend work; ensure you’re comfortable with the intensity before accepting.